Challenges and Opportunities in MENA Healthcare


Healthcare spending in the Middle East and North Africa (MENA) region has observed a significant rise over the past two to three decades. Several factors such as an increase in the elderly population, advancement in technology, increased health awareness, and lifestyle changes have resulted in high healthcare spending.


The MENA region’s pharma market is one of the most developed in the world. Currently, more than 140 companies operate in the region with both multinational and indigenous players. Over the past few years, several international companies have invested heavily in the healthcare segment; some of the global pharmaceutical giants have manufacturing facilities. Similarly, significantly progressed has been registered in higher medical education and research. Countries like UAE, Saudi Arabia, and others are strategically developing their healthcare system into a global medical tourism hub. 


As per the estimates, the MENA pharmaceutical market accounts for nearly 2% of the global market. The MENA region encompasses around 22 countries. Among these, Saudi Arabia holds almost 60% market share, followed by UAE. Currently, the UAE is one of the fastest-growing markets, and healthcare spending is expected to reach USD 2.5 billion in 2025 and USD 3.6 billion by 2030. Despite the favorable outcomes in the region’s healthcare system, few challenges hamper the healthcare market to attain full potential growth rate. 


In the coming years, the MENA Healthcare market is anticipated to grow. The primary factor includes a rise in health insurance, increasing income levels, a surge in the geriatric population, and the rising prevalence of lifestyle diseases. A high priority by the government and key initiatives by health authorities over the years has remarkably stimulated the Healthcare Market growth, which is expected to continue in the coming years. 


Read More: https://duphat.ae/what-is-fuelling-the-healthcare-market-space-in-the-mena/

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Hypothalamic Obesity Market by DelveInsight

  (New York, USA) DelveInsight’s “ Hypothalamic Obesity Market Insights, Epidemiology, and Market Forecast-2032 ” report delivers an in-depth understanding of Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hypothalamic Obesity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypothalamic Obesity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hypothalamic Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hypothalamic Obesity market. Request for a Free Sample Report @  Hypothalamic Obesity Market Forecast Some facts of the Hypothalamic Obesity Market Report are: Accordi
Read more

Test

  Partial Seizure Market | Parkinson's Disease Levodopa-Induced Dyskinesia Market | Metabolic Acidosis Market | Hepatitis D Market | Gaucher's disease Market | Gastric Neuroendocrine Tumours Market | Familial Chylomicronemia Syndrome Market | Exocrine Pancreatic Insufficiency Market | Crohn's Disease Market | Contact Dermatitis Market | Concussions Market Size | Chronic Bronchitis Market | Chondrosarcoma Market | Palmar Hyperhidrosis Market | Hpv Induced Cancers Market | Alstrom Syndrome Market | Astigmatism Market | Meningioma Market | Central Retinal Vein Occlusion Market | Intracranial Pressure Monitoring Devices Market | Head And Neck Squamous Cell Carcinoma Market | Hyperopia Market | Thyroid Eye Disease Market | Rett Syndrome Market | Cipn Market | Chemotherapy Induced Peripheral Neuropathy Market | Idiopathic Membranous Nephropathy Market | Walking Impairment In Multiple Sclerosis Market  |  Triple Negative Breast Cancer Market  | Sjogren&#
Read more